Fleischmann Daniel F, Unterrainer Marcus, Bartenstein Peter, Belka Claus, Albert Nathalie L, Niyazi Maximilian
Department of Radiation Oncology, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
J Neurooncol. 2017 Apr;132(2):277-286. doi: 10.1007/s11060-016-2366-8. Epub 2017 Jan 19.
Most high-grade gliomas (HGG) recur after initial multimodal therapy and re-irradiation (Re-RT) has been shown to be a valuable re-treatment option in selected patients. We evaluated the prognostic value of dynamic time-to-peak analysis and early static summation images in O-(2-F-fluoroethyl)-l-tyrosine (F-FET) PET for patients treated with Re-RT ± concomitant bevacizumab. We retrospectively analyzed 72 patients suffering from recurrent HGG with F-FET PET prior to Re-RT. PET analysis revealed the maximal tumor-to-background-ratio (TBR), the biological tumor volume, the number of PET-foci and pattern of time-activity-curves (TACs; increasing vs. decreasing). Furthermore, the novel PET parameters early TBR (at 5-15 min post-injection) and minimal time-to-peak (TTP) were evaluated. Additional analysis was performed for gender, age, KPS, O6-methylguanine-DNA methyltransferase methylation status, isocitrate dehydrogenase 1 mutational status, WHO grade and concomitant bevacizumab therapy. The influence of PET and clinical parameters on post-recurrence survival (PRS) was investigated. Shorter TTP was related to shorter PRS after Re-RT with 6 months for TTP < 12.5 min, 7 months for TTP 12.5-25 min and 11 months for TTP >25 min (p = 0.027). TTP had a significant impact on PRS both on univariate (p = 0.027; continuous) and multivariate analysis (p = 0.011; continuous). Other factors significantly related to PRS on multivariate analysis were increasing vs. decreasing TACs (p = 0.008) and Karnofsky Performance Score (p = 0.015; <70 vs. ≥70). Early TBR as well as the other conventional PET parameters were not significantly related to PRS on univariate analysis. Dynamic F-FET PET with TTP provides a high prognostic value for recurrent HGG prior to Re-RT, whereas early TBR does not. Dynamic F-FET PET using TTP might help to personalize Re-RT treatment regimens in future through voxelwise TTP analysis for dose painting purposes and PET-guided dose escalation.
大多数高级别胶质瘤(HGG)在初始多模式治疗后会复发,而再照射(Re-RT)已被证明是部分患者有价值的再治疗选择。我们评估了动态达峰时间分析和早期静态总和图像在O-(2-氟乙基)-L-酪氨酸(F-FET)PET中对接受Re-RT±贝伐单抗同步治疗患者的预后价值。我们回顾性分析了72例复发性HGG患者,这些患者在接受Re-RT之前进行了F-FET PET检查。PET分析显示了最大肿瘤与本底比值(TBR)、生物学肿瘤体积、PET病灶数量和时间-活性曲线(TAC;上升与下降)模式。此外,还评估了新的PET参数早期TBR(注射后5-15分钟)和最短达峰时间(TTP)。对性别、年龄、KPS、O6-甲基鸟嘌呤-DNA甲基转移酶甲基化状态、异柠檬酸脱氢酶1突变状态、世界卫生组织分级和贝伐单抗同步治疗进行了额外分析。研究了PET和临床参数对复发后生存期(PRS)的影响。较短的TTP与Re-RT后的较短PRS相关,TTP<12.5分钟时为6个月,TTP为12.5-25分钟时为7个月,TTP>25分钟时为11个月(p=0.027)。TTP在单因素分析(p=0.027;连续变量)和多因素分析(p=0.011;连续变量)中对PRS均有显著影响。多因素分析中其他与PRS显著相关的因素是TAC上升与下降(p=0.008)和卡诺夫斯基功能状态评分(p=0.015;<70与≥70)。早期TBR以及其他传统PET参数在单因素分析中与PRS无显著相关性。基于TTP的动态F-FET PET对复发性HGG患者在接受Re-RT之前具有较高的预后价值,而早期TBR则不然。使用TTP的动态F-FET PET未来可能有助于通过体素水平的TTP分析进行剂量描绘和PET引导的剂量递增来个性化Re-RT治疗方案。